|
|
||||||||
Animal: RNA Viruses |
Faculté de Médecine Vétérinaire, Université de Montréal, Département de Pathologie et Microbiologie, Section Virologie, C.P. 5000, St-Hyacinthe, Québec, Canada, J2S 7C61
Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Québec, Canada, J1K 2R12
Institut de Recherches Cliniques de Montréal, Université de Montréal, Montréal, Canada3
Department of Veterinary Science and Biology/Microbiology, College of Agriculture and Biological Sciences, South Dakota State University, USA4
Author for correspondence: Brian Talbot.Fax +1 819 821 8049. e-mail btalbot{at}courrier.usherb.ca
Bovine viral diarrhoea virus (BVDV) is an economically important pathogen of cattle that is ubiquitously distributed worldwide. In this study, cattle were immunized by intramuscular injections with plasmid DNA expressing the BVDV type 1 major glycoprotein E2. Animals either received injections of naked DNA (N-DNA) or DNA in cationic liposomes (L-DNA). Both DNA preparations induced virus-specific neutralizing antibodies in vaccinates, although the response was much lower in N-DNA-immunized animals. N-DNA-vaccinated animals also showed virus-specific lymphocyte proliferation responses to type 1, live BVDV in vitro, whereas L-DNA vaccination induced no such responses. After 16 weeks, DNA-vaccinated and mock-vaccinated animals were challenged with a USDA-certified BVDV type 1 strain. Four significant observations were made: (1) N-DNA-vaccinated calves showed limited protection from virus challenge, (2) L-DNA-vaccinated animals did not show any signs of protection, (3) the challenge induced strong memory responses in the production of serum neutralizing antibodies to both genotypes (type 1 and 2 of BVDV), and (4) the challenge induced a mucosal memory response in nasal secretions of both L- and N-DNA-vaccinated animals.
This article has been cited by other articles:
![]() |
W. Kohl, A. Grone, V. Moennig, and G. Herrler Expression of the surface glycoprotein E2 of Bovine viral diarrhea virus by recombinant vesicular stomatitis virus J. Gen. Virol., January 1, 2007; 88(1): 157 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liang, J. V. van den Hurk, L. A. Babiuk, and S. van Drunen Littel-van den Hurk Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2971 - 2982. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Donofrio, E. Bottarelli, C. Sandro, and C. F. Flammini Expression of Bovine Viral Diarrhea Virus Glycoprotein E2 as a Soluble Secreted Form in a Mammalian Cell Line Clin. Vaccine Immunol., June 1, 2006; 13(6): 698 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, J. O. Sunyer, and L. J. Bello Fusion to C3d Enhances the Immunogenicity of the E2 Glycoprotein of Type 2 Bovine Viral Diarrhea Virus J. Virol., February 15, 2004; 78(4): 1616 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. M. Shoda, K. A. Kegerreis, C. E. Suarez, W. Mwangi, D. P. Knowles, and W. C. Brown Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-{alpha}, and NO production by bovine macrophages J. Leukoc. Biol., July 1, 2001; 70(1): 103 - 112. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |